Biology subjects

Mansson, A.

Publications and source records attributed to Mansson, A..

5 recordsLinked to original sources

bioRxiv2026

Myotropes unveil two myosin cycles with distinct kinetics and stroke size

Cardiac contraction relies on cyclic interactions between myosin II motors and actin filaments, powered by the free energy of ATP turnover. Targeting of this fundamental process has emerged as a promising therapeutic strategy; Mavacamten, a cardiac myosin inhibitor was recently approved for treating obstructive hypertrophic cardiomyopathy whereas omecamtiv mecarbil was developed as a myosin activator for heart failure. Both myotropes bind to the same myosin pocket but their mechanisms of action remain incompletely understood. Here, we investigate these using optical tweezers mechanoenzymology and single-molecule fluorescence-based actomyosin kinetics applied to {beta}-myosin from donor hearts and recombinant human {beta}-myosin subfragment 1. Our findings reveal unexpected layers of complexity. Both mavacamten and omecamtiv mecarbil partially slow the ATP turnover, giving one fast (similar to physiological) and one drug-induced slow ATP turnover cycle at saturating drug concentrations with different rate-limiting steps for the two compounds. In one of the parallel cycles, mavacamten increases stroke size and appreciably delays the power-stroke, allowing direct visualization of a strongly bound pre-power-stroke state. No power-stroke delay is seen in the other cycle, but a reduced stroke size is observed. Our findings uncover a new paradigm in cardiac regulation at the single-molecule level, demonstrating partial inhibition of myosin as a powerful therapeutic strategy.

biophysics↗

bioRxiv2023

New paradigms in actomyosin energy transduction: critical evaluation of non-traditional models for orthophosphate release

Release of the ATP hydrolysis product inorganic phosphate (Pi) from the active site of myosin is central in chemo-mechanical energy transduction and closely associated with the main force-generating structural change, the power-stroke. Despite intense investigations, the relative timing between Pi-release and the power-stroke remains poorly understood. This hampers in depth understanding of the production of force and motion by myosin in health and disease and also our understanding of myosin-active drugs. From the 1990s and up to today, models with the Pi-release either distinctly before or after the power-stroke, in unbranched kinetic schemes, have dominated the literature. However, in recent years, alternative models have emerged to explain apparently contradictory findings. Here, we first compare and critically analyze, three influential alternative models, either characterized by a branched kinetic scheme or by partial uncoupling of Pi-release and the power-stroke. Finally, we suggest critical tests of the models aiming for a unified picture.

biophysics↗

bioRxiv2022

High cardiomyocyte diversity in human early prenatal heart development

Cardiomyocytes play key roles during cardiogenesis, but have poorly understood features, especially in prenatal stages. Thus, we have characterized human prenatal cardiomyocytes, 6.5- 7 weeks post-conception, in detail by integrating single-cell RNA sequencing, spatial transcriptomics, and ligand-receptor interaction information. Using a computational workflow developed to dissect cell type heterogeneity, localize cell types, and explore their molecular interactions, we identified eight types of developing cardiomyocyte, more than double compared to the ones identified in the Human Developmental Cell Atlas. These have high variability in cell cycle activity, mitochondrial content, and connexin gene expression, and are differentially distributed in the ventricles, including outflow tract, and atria, including sinoatrial node. Moreover, cardiomyocyte ligand-receptor crosstalk is mainly with non-cardiomyocyte cell types, encompassing cardiogenesis-related pathways. Thus, early prenatal human cardiomyocytes are highly heterogeneous and develop unique location-dependent properties, with complex ligand-receptor crosstalk. Further elucidation of their developmental dynamics may give rise to new therapies. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=194 SRC="FIGDIR/small/482029v1_ufig1.gif" ALT="Figure 1"> View larger version (76K): org.highwire.dtl.DTLVardef@1385cb8org.highwire.dtl.DTLVardef@14f62d1org.highwire.dtl.DTLVardef@e0b10borg.highwire.dtl.DTLVardef@1876345_HPS_FORMAT_FIGEXP M_FIG C_FIG

systems biology↗

bioRxiv2020

Myosin-gelsolin cooperativity in actin filament severing and actomyosin motor activity

Actin is a major intracellular protein with key functions in cellular motility, signalling and structural rearrangements. Its dynamic behavior with actin filaments (F-actin) polymerising and depolymerising in response to intracellular changes, is controlled by actin-binding proteins (ABPs). Gelsolin is one of the most potent filament severing ABPs. However, myosin motors that interact with actin in the presence of ATP also produce actin filament fragmentation through motor induced shearing forces. To test the idea that gelsolin and myosin cooperate in these processes we used the in vitro motility assay, where actin filaments are propelled by surface-adsorbed heavy meromyosin (HMM) motor fragments. This allows studies of both motility and filament dynamics using isolated proteins. Gelsolin (5 nM) at very low [Ca2+] (free [Ca2+] [~]6.8 nM) appreciably enhanced actin filament severing caused by HMM-induced forces at 1 mM [MgATP], an effect that was increased at increased HMM motor density. This finding is consistent with cooperativity between actin filament severing by myosin-induced forces and by gelsolin. As further support of myosin-gelsolin cooperativity we observed reduced sliding velocity of the HMM propelled filaments in the presence of gelsolin. Overall, the results corroborate ideas for cooperative effects between gelsolin-induced alterations in the actin filaments and changes due to myosin motor activity, leading among other effects to enhanced F-actin severing of possible physiological relevance.

biophysics↗

bioRxiv2020

Optimized single molecule fluorescence sheds light on elusive enzymatic mechanisms

Single molecule enzymology using fluorescent substrate requires truly minimal amounts of proteins. This is highly beneficial when the protein source is either advanced expression systems or samples from humans/animals with ethical and economic implications. Further benefits of single molecule analysis is the potential to reveal phenomena hidden in ensemble studies. However, dye photophysics and fluorescent contaminants complicate interpretation of the single molecule data. We here corroborate the importance of such complexities using fluorescent Alexa647 ATP to study ATP turnover by myosin and actomyosin. We further show that the complexities are largely eliminated by aggressive surface cleaning and use of a range of triple state quenchers and redox agents with minor effects on actin-myosin function. Using optimized assay conditions, we then show that the distributions of ATP binding dwell times on myosin are best described by the sum of 2 to 3 exponential processes. This applies in the presence and absence of actin and in the presence and absence of the drug para-aminoblebbistatin. Two of the processes are attributable to ATP turnover by myosin and actomyosin, respectively. A remaining process with rate constant in the range 0.2-0.5 s-1 is consistent with non-specific ATP binding to myosin and bioinformatics modelling suggests that such binding may be important for accelerated ATP transport to the active site. Finally, we report studies of the actin-activated myosin ATP turnover under conditions with no sliding between actin and myosin, as in isometrically contracting muscle, revealing heterogeneity in the ATP turnover kinetics between different molecules.

biophysics↗